23 reports

  • EUROPE OXYGEN THERAPY EQUIPMENT MARKET
  • EUROPE OXYGEN THERAPY EQUIPMENT MARKET

DISEASES COVERED UNDER SUCH PROGRAMS INCLUDE MOST CARDIOVASCULAR & GASTROINTESTINAL DISORDERS, ASTHMA, BREAST CANCER, CHRONIC-OBSTRUCTIVE PULMONARY DISEASE, CORONARY HEART DISEASE & HEART FAILURE, DIABETES ETC.

  • Respiratory Device
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • Respiratory Device
  • Asia
  • India
  • Forecast
  • Market Size

MERGER AND ACQUISITION ASTRA ZENECA (2015) FIGURE ##: ASTRA ZENECA REVENUE BY SEGMENTS CARDIOVASCULAR & METABOLIC DISEASES ONCOLOGY RESPIRATORY, INFLAMMATION AND AUTOIMMUNITY INFECTION, NEUROSCIENCE AND GASTROINTESTINAL ##% ##% ##% ##% (2015) FIGURE ##: ASTRA ZENECA REVENUE, BY RESPIR

  • Respiratory Device
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • The company's strategic objective is to collaborate with other vendors to expand

Discovers, develops, and commercializes prescription medicines for the cardiovascular, gastrointestinal, neuroscience, oncology, respiratory, and inflammation AEROGEN AIRON ASTRAZENECA Description DEVILBISS HEALTHCARE BRIGGS HEALTHCARE BOEHRINGER INGELHEIM areas.

  • Respiratory Device
  • Bespak plc
  • Consort Medical plc
  • Gerresheimer AG
  • Nypro Inc.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Device
  • Europe
  • Russian Federation
  • Forecast
  • CareFusion Corporation

These surgeries help treat diseases such as hypertension, cardiovascular diseases, gastrointestinal diseases, urological diseases, spinal abnormalities, brain tumors, and orthopedic deformities.

  • Respiratory Device
  • World
  • Market Size
  • Airways Corporation
  • Teleflex Incorporated

The company offers products in the areas of anaesthesia and pain control, cardiovascular disease, central nervous system, gastrointestinal disorders, infection, oncology, and respiratory disease.

  • Respiratory Device
  • Asia
  • World
  • Market Size
  • AstraZeneca PLC
  • Medical Equipment
  • Respiratory Device
  • Asia
  • South Korea
  • Pfizer Inc.

WHEN AGGRESSIVE, THESE TUMOURS ARE FATAL AND CAN SPREAD QUICKLY TO THE GASTROINTESTINAL TRACT AND THE LUNGS.

  • Pharmaceutical
  • Respiratory Device
  • North America
  • United States
  • Pfizer Inc.
  • LMA FLEXIBLE GASTRIC ACCESS DEVICE - PRODUCT DESCRIPTION
  • ENDO-TRACHEAL TUBE - PRODUCT STATUS
  • Clinical Trial
  • Medical Device
  • Respiratory Device
  • United States
  • GlobalData's company
  • Hospital
  • Respiratory Device
  • Europe
  • Germany
  • Pfizer Inc.
  • WIPOX - PRODUCT DESCRIPTION
  • Clinical Trial
  • Medical Device
  • Respiratory Device
  • United States
  • GlobalData's company

NEW APPROVALS AND REGULATORY OPINIONS THE EC APPROVED AFINITOR (EVEROLIMUS) FOR THE TREATMENT OF UNRESECTABLE OR METASTATIC, WELL-DIFFERENTIATED NONFUNCTIONAL NEUROENDOCRINE TUMORS OF GASTROINTESTINAL OR LUNG ORIGIN IN ADULTS WITH PROGRESSIVE DISEASE.

  • Respiratory Device
  • Europe
  • Company Financials
  • Forecast
  • Boehringer Ingelheim GmbH
  • LMA FLEXIBLE GASTRIC ACCESS DEVICE - PRODUCT DESCRIPTION
  • ENDO-TRACHEAL TUBE - PRODUCT STATUS
  • Clinical Trial
  • Medical Device
  • Respiratory Device
  • United States
  • GlobalData's company

Key growth drivers New approvals and regulatory opinions The EC approved Afinitor (everolimus) for the treatment of unresectable or metastatic, well-differentiated nonfunctional neuroendocrine tumors of gastrointestinal or lung origin in adults with progressive disease.

  • Air Way Device
  • Respiratory Device
  • United States
  • Company Financials
  • GlobalData's company

REDDY S FOCUSED ON MAKING GENERIC AND COMPLEX PRODUCTS ACROSS THE MAJOR THERAPEUTIC AREAS OF GASTROINTESTINAL, CARDIOVASCULAR, DIABETOLOGY, ONCOLOGY, PAIN MANAGEMENT AND DERMATOLOGY. ##. ##. ## SEP ##, 2016: PIRAMAL PLANS TO EXPAND ITS API DEVELOPMENT & MANUFACTURING CAPABILITIES AT DIGWAL

  • Hospital
  • Respiratory Device
  • Asia
  • India
  • Pfizer Inc.
  • TPAD DEVICE - PRODUCT STATUS
  • TPAD DEVICE - PRODUCT DESCRIPTION

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Clinical Trial
  • Respiratory Device
  • Therapy
  • United States
  • GlobalData's company

POST A SUCCESSFUL STINT IN THIS ROLE, HE MOVED TO THE UNITED KINGDOM AS GLOBAL HEAD OF ESTABLISHED BRANDS AND GLOBAL MEDICAL LEAD GASTROINTESTINAL/ CARDIO VASCULAR.

  • Health Care Provider
  • Respiratory Device
  • Europe
  • United Kingdom
  • Pfizer Inc.

an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, reported the presentation of two posters at the American Society for Clinical

  • Respiratory Device
  • North America
  • Demand
  • Forecast
  • Philips Respironics, Inc.

an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, reported the presentation of two posters at the American Society for Clinical

  • Respiratory Device
  • United States
  • Demand
  • Philips Respironics, Inc.

In addition, the company' s BÂRRX gastrointestinal business grew more than ##% during the quarter, as did the company' s interventional lung business.

  • Clinical Trial
  • Respiratory Device
  • Respiratory Monitoring
  • United States
  • GlobalData's company

The system has the performance and versatility for use in common and advanced general laparoscopic procedures, including laparoscopic cholecystectomy, upper gastrointestinal, gastric, bariatric, and colorectal and hernia.

  • Patient Monitoring
  • Respiratory Device
  • World
  • Forecast
  • Teleflex Incorporated